{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:56:37Z","timestamp":1792788997658,"version":"4.5.0"},"reference-count":23,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Merck Sharp","award":["58756"],"award-info":[{"award-number":["58756"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>(1) Background: Resistant Pseudomonas aeruginosa (PA) infections have limited treatment options. Data on the activity of ceftolozane-tazobactam (C-T) against PA in Thailand are limited. Objectives: The objective of this study was to identify the in vitro activity of C-T against general and resistant PA isolates from patients with real clinical infections from the HRH Princess Maha Chakri Sirindhorn Medical Center (MSMC) compared to other antibiotics and to study the resistant molecular patterns of those PA strains which were resistant to C-T. (2) Materials and Methods: This was an in vitro susceptibility study of 100 PA isolates plus an additional seven resistant PA isolates collected from MSMC patients. All PA isolates were tested with susceptibility broth (Sensititre\u2122) and C-T minimal inhibitory concentration (MIC) test strips (Liofilchem, Roseto degli, Abruzzi, Italy). The C-T-resistant PA isolates were analyzed for six \u03b2-lactamase genes (blaCTX-M, blaNDM, blaIMP, blaVIM, blaOXA-23 and blaOXA-48) and the mcr-1 gene. (3) Results: A total of 100 PA isolates were collected between January 2020 and January 2021 and between February 2021 and September 2021 for the additional 7 resistant isolates. There were 18 resistant PA isolates (6 MDR, 11 XDR and 1 pan-drug resistant isolate). The overall susceptibility of the initial 100 PA isolates and the 18 resistant PA isolates was 94% and 44.5%, respectively, for C-T. The C-T susceptibility rates for isolates non-susceptible to ceftazidime, piperacillin-tazobactam, carbapenems and antipseudomonal \u03b2-lactams were 65.5%, 69.7%, 50% and 44.5%, respectively. Among the 10 isolates which were resistant to C-T, there were only 3 isolates found to have the resistant gene, which included 1 for blaIMP, 1 for blaVIM and 1 for blaNDM. (4) Conclusions: Although C-T was the best susceptibility antibiotic overall for PA isolates and MDR PA isolates at the MSMC, most of the XDR PA isolates and the PDR PA isolate were not susceptible to C-T. The mechanisms for C-T resistance involved multiple factors including the presence of blaIMP, blaVIM and blaNDM.<\/jats:p>","DOI":"10.3390\/antibiotics11060732","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T10:05:14Z","timestamp":1653905114000},"page":"732","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["In Vitro Activity of Ceftolozane-Tazobactam and Other Antibiotics against Pseudomonas aeruginosa Infection-Isolates from an Academic Medical Center in Thailand"],"prefix":"10.3390","volume":"11","author":[{"given":"Woraphot","family":"Tantisiriwat","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine, HRH Princess Maha Chakri Sirindhorn Medical Center, Faculty of Medicine, Srinakharinwirot University, Nakhon Nayok 26120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirawat","family":"Buppanharun","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, HRH Princess Maha Chakri Sirindhorn Medical Center, Faculty of Medicine, Srinakharinwirot University, Nakhon Nayok 26120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chatchai","family":"Ekpanyaskul","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, HRH Princess Maha Chakri Sirindhorn Medical Center, Faculty of Medicine, Srinakharinwirot University, Nakhon Nayok 26120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwanchai","family":"Onruang","sequence":"additional","affiliation":[{"name":"Department of Pathology, HRH Princess Maha Chakri Sirindhorn Medical Center, Faculty of Medicine, Srinakharinwirot University, Nakhon Nayok 26120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thitiya","family":"Yungyuen","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattarachai","family":"Kiratisin","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somchai","family":"Santiwatanakul","sequence":"additional","affiliation":[{"name":"Department of Pathology, HRH Princess Maha Chakri Sirindhorn Medical Center, Faculty of Medicine, Srinakharinwirot University, Nakhon Nayok 26120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,30]]},"reference":[{"key":"ref_1","unstructured":"Centers of Disease Control and Prevention (2021, December 14). Pseudomonas aeruginosa, Healthcare Settings, Available online: https:\/\/www.cdc.gov\/hai\/organisms\/pseudomonas.html."},{"key":"ref_2","unstructured":"Centers for Disease Control and Prevention (2021, December 14). Antibiotic Resistance Threats in the United States, Available online: https:\/\/www.cdc.gov\/drugresistance\/pdf\/threats-report\/2019-ar-threats-report-508.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/CCM.0000000000004371","article-title":"Key Takeaways from the U.S. CDC\u2019s 2019 Antibiotic Resistance Threats Report for Frontline Providers","volume":"48","author":"Kadri","year":"2020","journal-title":"Crit. Care Med."},{"key":"ref_4","first-page":"S68","article-title":"National Antimicrobial Resistance Surveillance, Thailand (NARST) Data among Clinical Isolates of Pseudomonas aeruginosa in Thailand from 2000 to 2005","volume":"92","author":"Dejsirilert","year":"2009","journal-title":"J. Med. Assoc. Thai."},{"key":"ref_5","unstructured":"(2021, December 14). The National Antimicrobial Resistance Surveillance, Thailand (NARST): Antimicrobial Resistance Rates of P. aeruginosa from 2000\u20132020. Available online: http:\/\/www.narst.dmsc.moph.go.th\/data\/AMR%202000-2020-12M.pdf."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13756-016-0115-6","article-title":"Epidemiology and Molecular Characterization of Multidrug-resistant Gram-Negative Bacteria in Southeast Asia","volume":"5","author":"Suwantarat","year":"2016","journal-title":"Antimicrob. Resist Infect. Control"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1128\/AAC.00207-10","article-title":"Impact of Multidrug-Resistant Pseudomonas aeruginosa Bacteremia on Patient Outcomes","volume":"54","author":"Tam","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1017\/S0950268810003055","article-title":"Multidrug-Resistant Pseudomonas aeruginosa Bloodstream Infections: Risk Factors and Mortality","volume":"139","author":"Tumbarello","year":"2011","journal-title":"Epidemiol. Infect."},{"key":"ref_9","first-page":"441","article-title":"Impact of Multidrug-Resistant Pseudomonas aeruginosa Infection on Patient Outcomes","volume":"10","author":"Hirsch","year":"2010","journal-title":"Expert Rev. Pharm. Outcomes Res."},{"key":"ref_10","unstructured":"Tamma, P.D., Aitken, S.L., Bonomo, R.A., Mathers, A.J., van Duin, D., and Clancy, C.J. (2021, December 14). Infectious Diseases Society of America Antimicrobial-Resistant Treatment Guidance: Gram-Negative Bacterial Infections. Infectious Diseases Society of America 2020; Version 1.0. Available online: https:\/\/www.idsociety.org\/practice-guideline\/amr-guidance\/."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_12","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2021). Performance Standards for Antimicrobial Susceptibility Testing, Clinical and Laboratory Standards Institute. [32nd ed.]. CLSI Supplement M100."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1128\/AAC.00171-08","article-title":"Molecular Characterization and Epidemiology of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates Causing Health Care-associated Infection in Thailand, where the CTX-M Family is Endemic","volume":"52","author":"Kiratisin","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","article-title":"Multiplex PCR for Detection of Acquired Carbapenemase Genes","volume":"70","author":"Poirel","year":"2011","journal-title":"Diagn. Microbiol. Infect Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jac\/dkl481","article-title":"Multiplex PCR for Rapid Detection of Genes Encoding Acquired Metallo-Beta-Lactamases","volume":"59","author":"Ellington","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13756-018-0410-5","article-title":"Prevalence of Different Carbapenemase Genes among Carbapenem-Resistant Acinetobacter baumannii Blood Isolates in Taiwan","volume":"7","author":"Wang","year":"2018","journal-title":"Antimicrob. Resist Infect. Control"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijantimicag.2006.01.004","article-title":"Multiplex PCR for Genes Encoding Prevalent OXA Carbapenemases in Acinetobacter spp.","volume":"27","author":"Woodford","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of Plasmid-Mediated Colistin Resistance Mechanism MCR-1 in Animals and Human Beings in China: A Microbiological and Molecular Biological Study","volume":"16","author":"Liu","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Srinivasan, R., Karaoz, U., Volegova, M., MacKichan, J., Kato-Maeda, M., Miller, S., Nadarajan, R., Brodie, E., and Lynch, S.V. (2015). Use of 16S rRNA Gene for Identification of a Broad Range of Clinically Relevant Bacterial Pathogens. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117617"},{"key":"ref_20","first-page":"S2213-7165(21)00264-2","article-title":"In Vitro Activity of Ceftolozane\/Tazobactam against Gram-Negative Isolates Collected from ICU Patients with Lower Respiratory Tract Infections in Seven Asian Countries\u2014SMART 2017\u20132019","volume":"8","author":"Lob","year":"2021","journal-title":"J. Glob Antimicrob. Resist."},{"key":"ref_21","unstructured":"Food and Drug Administration Thailand (2022, April 04). Detail of Medical Product: Zerbaxa. Available online: http:\/\/pertento.fda.moph.go.th\/FDA_SEARCH_DRUG\/SEARCH_DRUG\/pop-up_drug_ex.aspx?Newcode=U1DR2C1012600001811C."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3947\/ic.2019.51.2.107","article-title":"Dissemination of Carbapenem-Resistance among Multidrug Resistant Pseudomonas aeruginosa Carrying Metallo-Beta-Lactamase Genes, including the Novel blaIMP-65 Gene in Thailand","volume":"51","author":"Khuntayaporn","year":"2019","journal-title":"Infect. Chemother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2475067","DOI":"10.1155\/2016\/2475067","article-title":"Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens","volume":"2016","author":"Santajit","year":"2016","journal-title":"Biomed. Res. Int."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/6\/732\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:21:08Z","timestamp":1760138468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/6\/732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["antibiotics11060732"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics11060732","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,30]]}}}